Skip to main content
Top
Published in: Critical Care 5/2002

Open Access 01-10-2002 | Research

Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve?

Authors: Albertus Beishuizen, Lambertus G Thijs, István Vermes

Published in: Critical Care | Issue 5/2002

Login to get access

Abstract

Introduction

Dehydroepiandrosterone (DHEA) and its sulphate (DHEAS) are pleiotropic adrenal hormones with immunostimulating and antiglucocorticoid effects. The present study was conducted to evaluate the time course of DHEAS levels in critically ill patients and to study their association with the hypothalamic–pituitary–adrenal axis.

Materials and method

This was a prospective observational clinical and laboratory study, including 30 patients with septic shock, eight patients with multiple trauma, and 40 age- and sex-matched control patients. We took serial measurements of blood concentrations of DHEAS, cortisol, tumour necrosis factor-α and IL-6, and of adrenocorticotrophic hormone immunoreactivity over 14 days or until discharge/death.

Results

On admission, DHEAS was extremely low in septic shock (1.2 ± 0.8 mol/l) in comparison with multiple trauma patients (2.4 ± 0.5 μmol/l; P < 0.05) and control patients (4.2 ± 1.8; P < 0.01). DHEAS had a significant (P < 0.01) negative correlation with age, IL-6 and Acute Physiology and Chronic Health Evaluation II scores in both patient groups. Only during the acute phase did DHEAS negatively correlate with dopamine. Nonsurvivors of septic shock (n = 11) had lower DHEAS levels (0.4 ± 0.3 μmol/l) than did survivors (1.7 ± 1.1 μmol/l; P < 0.01). The time course of DHEAS exhibited a persistent depletion during follow up, whereas cortisol levels were increased at all time points.

Conclusion

We identified extremely low DHEAS levels in septic shock and, to a lesser degree, in multiple trauma patients as compared with those of age- and sex-matched control patients. There appeared to be a dissociation between DHEAS (decreased) and cortisol (increased) levels, which changed only slightly over time. Nonsurvivors of sepsis and patients with relative adrenal insufficiency had the lowest DHEAS values, suggesting that DHEAS might be a prognostic marker and a sign of exhausted adrenal reserve in critical illness.
Literature
1.
go back to reference Ebeling P, Koivisto VA: Physiological importance of dehydroepiandrosterone. Lancet 1994, 343: 1479-1481. 10.1016/S0140-6736(94)92587-9CrossRefPubMed Ebeling P, Koivisto VA: Physiological importance of dehydroepiandrosterone. Lancet 1994, 343: 1479-1481. 10.1016/S0140-6736(94)92587-9CrossRefPubMed
2.
go back to reference Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidling-maier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B: Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999, 341: 1013-1020. 10.1056/NEJM199909303411401CrossRefPubMed Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidling-maier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B: Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999, 341: 1013-1020. 10.1056/NEJM199909303411401CrossRefPubMed
3.
go back to reference Oberbeck R, Dahlweid M, Koch R, van Griensven M, Emmendörfer A, Tscherne H, Pape HC: Dehydroepiandrosterone decreases mortality and improves cellular immune function during polymicrobial sepsis. Crit Care Med 2001, 29: 380-384. 10.1097/00003246-200102000-00029CrossRefPubMed Oberbeck R, Dahlweid M, Koch R, van Griensven M, Emmendörfer A, Tscherne H, Pape HC: Dehydroepiandrosterone decreases mortality and improves cellular immune function during polymicrobial sepsis. Crit Care Med 2001, 29: 380-384. 10.1097/00003246-200102000-00029CrossRefPubMed
4.
go back to reference Achermann JC, Silverman BL: Dehydroepiandrosterone replacement for patients with adrenal insufficiency. Lancet 2001, 357: 1381-1382. 10.1016/S0140-6736(00)04617-1CrossRefPubMed Achermann JC, Silverman BL: Dehydroepiandrosterone replacement for patients with adrenal insufficiency. Lancet 2001, 357: 1381-1382. 10.1016/S0140-6736(00)04617-1CrossRefPubMed
5.
go back to reference Beishuizen A, Vermes I, Hylkema BS, Haanen C: Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet 1999, 353: 1675-1676. 10.1016/S0140-6736(99)01346-XCrossRefPubMed Beishuizen A, Vermes I, Hylkema BS, Haanen C: Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet 1999, 353: 1675-1676. 10.1016/S0140-6736(99)01346-XCrossRefPubMed
6.
go back to reference Beishuizen A, Thijs LG: Relative adrenal failure in intensive care: an identifiable problem requiring treatment? Best Pract Res Clin Endocrinol Metab 2001, 15: 513-531. 10.1053/beem.2001.0167CrossRefPubMed Beishuizen A, Thijs LG: Relative adrenal failure in intensive care: an identifiable problem requiring treatment? Best Pract Res Clin Endocrinol Metab 2001, 15: 513-531. 10.1053/beem.2001.0167CrossRefPubMed
7.
go back to reference Parker LN, Levin ER, Lifrak ET: Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 1985, 60: 947-952.CrossRefPubMed Parker LN, Levin ER, Lifrak ET: Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 1985, 60: 947-952.CrossRefPubMed
8.
go back to reference Luppa P, Munker R, Nagel D, Weber M, Engelhardt D: Serum androgens in intensive-care patients: correlations with clinical findings. Clin Endocrinol (Oxf) 1991, 34: 305-310.CrossRef Luppa P, Munker R, Nagel D, Weber M, Engelhardt D: Serum androgens in intensive-care patients: correlations with clinical findings. Clin Endocrinol (Oxf) 1991, 34: 305-310.CrossRef
9.
go back to reference Van den Berghe G, de Zegher F, Wouters P, Schetz M, Verwaest C, Ferdinande P, Lauwers P: Dehydroepiandrosterone sulphate in critical illness: effect of dopamine. Clin Endocrinol (Oxf) 1995, 43: 457-463.CrossRef Van den Berghe G, de Zegher F, Wouters P, Schetz M, Verwaest C, Ferdinande P, Lauwers P: Dehydroepiandrosterone sulphate in critical illness: effect of dopamine. Clin Endocrinol (Oxf) 1995, 43: 457-463.CrossRef
10.
go back to reference Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Scholmerich J, Falk W, Lang B: Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 1998, 83: 2012-2017.CrossRefPubMed Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Scholmerich J, Falk W, Lang B: Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 1998, 83: 2012-2017.CrossRefPubMed
11.
go back to reference Mastorakos G, Chrousos GP, Weber JS: Recombinant interleukin-6 activates the hypothalamic–pituitary–adrenal axis in humans. J Clin Endocrinol Metab 1993, 77: 1690-1694.PubMed Mastorakos G, Chrousos GP, Weber JS: Recombinant interleukin-6 activates the hypothalamic–pituitary–adrenal axis in humans. J Clin Endocrinol Metab 1993, 77: 1690-1694.PubMed
12.
go back to reference Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF: DHEA and DHEA-S: a review. J Clin Pharmacol 1999, 39: 327-348. 10.1177/00912709922007903CrossRefPubMed Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF: DHEA and DHEA-S: a review. J Clin Pharmacol 1999, 39: 327-348. 10.1177/00912709922007903CrossRefPubMed
13.
go back to reference Baulieu E-E: Dehydroepiandrosterone (DHEA): a fountain of youth? J Clin Endocrinol Metabol 1996, 81: 3147-3151.CrossRef Baulieu E-E: Dehydroepiandrosterone (DHEA): a fountain of youth? J Clin Endocrinol Metabol 1996, 81: 3147-3151.CrossRef
Metadata
Title
Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve?
Authors
Albertus Beishuizen
Lambertus G Thijs
István Vermes
Publication date
01-10-2002
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2002
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc1530

Other articles of this Issue 5/2002

Critical Care 5/2002 Go to the issue